[go: up one dir, main page]

BRPI0606169A2 - preparo de rosuvastatina - Google Patents

preparo de rosuvastatina

Info

Publication number
BRPI0606169A2
BRPI0606169A2 BRPI0606169-9A BRPI0606169A BRPI0606169A2 BR PI0606169 A2 BRPI0606169 A2 BR PI0606169A2 BR PI0606169 A BRPI0606169 A BR PI0606169A BR PI0606169 A2 BRPI0606169 A2 BR PI0606169A2
Authority
BR
Brazil
Prior art keywords
rosuvastatin
preparation
rosuvastatin preparation
processes
intermediates
Prior art date
Application number
BRPI0606169-9A
Other languages
English (en)
Inventor
Anna Balanov
Valerie Niddam-Hildesheim
Natalia Shenkar
Original Assignee
Teva Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/360,725 external-priority patent/US20070037979A1/en
Application filed by Teva Pharma Ltd filed Critical Teva Pharma Ltd
Publication of BRPI0606169A2 publication Critical patent/BRPI0606169A2/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PREPARO DE ROSUVASTATINA. São fornecidos processos para o preparo de intermediários de rosuvastatina e seu uso no preparo de rosuvastatina e sais da rosuvastatina.
BRPI0606169-9A 2005-10-04 2006-10-04 preparo de rosuvastatina BRPI0606169A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US72387505P 2005-10-04 2005-10-04
US73297905P 2005-11-02 2005-11-02
US75107905P 2005-12-15 2005-12-15
US76050606P 2006-01-19 2006-01-19
US76234806P 2006-01-25 2006-01-25
US11/360,725 US20070037979A1 (en) 2005-02-22 2006-02-22 Preparation of rosuvastatin
PCT/US2006/038921 WO2007041666A1 (en) 2005-10-04 2006-10-04 Preparation of rosuvastatin

Publications (1)

Publication Number Publication Date
BRPI0606169A2 true BRPI0606169A2 (pt) 2009-06-02

Family

ID=39595929

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606169-9A BRPI0606169A2 (pt) 2005-10-04 2006-10-04 preparo de rosuvastatina

Country Status (5)

Country Link
JP (1) JP2008521836A (pt)
BR (1) BRPI0606169A2 (pt)
CA (1) CA2625290A1 (pt)
IL (1) IL187948A0 (pt)
MX (1) MX2007006647A (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2172471B1 (en) * 2007-04-18 2013-03-27 Teva Pharmaceutical Industries, Ltd. A process for preparing intermediates of HMG-CoA reductase inhibitors
EP3022213B1 (en) * 2013-07-16 2017-06-21 Suven Life Sciences Limited Process for the preparation of rosuvastatin calcium and preparation of its novel intermediates
EP3103878A4 (en) 2014-02-06 2017-08-16 API Corporation Rosuvastatin calcium and process for producing intermediate thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3400038B2 (ja) * 1993-10-19 2003-04-28 塩野義製薬株式会社 ピリミジン誘導体の製造方法
KR100511533B1 (ko) * 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
CN1742000A (zh) * 2002-12-10 2006-03-01 兰贝克赛实验室有限公司 制备若舒伐他汀的方法

Also Published As

Publication number Publication date
MX2007006647A (es) 2007-07-25
IL187948A0 (en) 2008-03-20
JP2008521836A (ja) 2008-06-26
CA2625290A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
UY32649A (es) "sales de 4-(dimetilamino)butil 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil)acetato"
TW200640878A (en) Preparation of rosuvastatin
BRPI0924183A2 (pt) inibidores de proteína quinase, formas cristalinas, formulações farmacêuticas e uso
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0814267A2 (pt) Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
UY32203A (es) Amino pirimidinas y su uso en terapia
BRPI0507118A (pt) polipeptìdeos de interferon humano modificado e seus usos
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
UY29853A1 (es) Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas-
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
BRPI0813237B8 (pt) composto, método para preparar o composto, medicamento, e, uso do composto
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0719345A2 (pt) Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
CL2006001266A1 (es) Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas.
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
EA201000258A1 (ru) Новые гербициды
BRPI0815768A2 (pt) Uso de absorventes de uv, e, composição cosmética.
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
GT200600520A (es) Agentes antibacterianos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.